↓ Skip to main content

Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study

Overview of attention for article published in Breast Cancer Research and Treatment, August 2010
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
246 Dimensions

Readers on

mendeley
158 Mendeley
Title
Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
Published in
Breast Cancer Research and Treatment, August 2010
DOI 10.1007/s10549-010-1103-9
Pubmed ID
Authors

Jens Huober, Gunter von Minckwitz, Carsten Denkert, Hans Tesch, Erich Weiss, Dirk Michael Zahm, Antje Belau, Fariba Khandan, Maik Hauschild, Christoph Thomssen, Bernhard Högel, Silvia Darb-Esfahani, Keyur Mehta, Sibylle Loibl

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Unknown 156 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 25 16%
Student > Ph. D. Student 23 15%
Student > Master 20 13%
Student > Doctoral Student 11 7%
Other 11 7%
Other 32 20%
Unknown 36 23%
Readers by discipline Count As %
Medicine and Dentistry 78 49%
Biochemistry, Genetics and Molecular Biology 12 8%
Agricultural and Biological Sciences 9 6%
Nursing and Health Professions 4 3%
Pharmacology, Toxicology and Pharmaceutical Science 3 2%
Other 9 6%
Unknown 43 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2013.
All research outputs
#7,535,755
of 22,992,311 outputs
Outputs from Breast Cancer Research and Treatment
#1,674
of 4,677 outputs
Outputs of similar age
#33,945
of 95,168 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#19
of 47 outputs
Altmetric has tracked 22,992,311 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,677 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,168 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.